Fabius Armida W M, van Hoefen Wijsard Milo, van Leeuwen Flora E, Moll Annette C
Department of Ophthalmology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.
Department of Epidemiology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Cancers (Basel). 2021 Mar 10;13(6):1200. doi: 10.3390/cancers13061200.
Retinoblastoma (Rb) is a pediatric malignant eye tumor. Subsequent malignant neoplasms (SMNs) and trilateral Rb (TRb) are the leading cause of death in heritable Rb patients in developed countries. The high rate of SMNs in heritable Rb patients is attributed to the presence of a mutation in the tumor suppressor gene. In addition, Rb therapy choices also influence SMN incidence in this patient group. The incidence rates and age of occurrence for the most frequent SMNs and TRb will be discussed. In addition, the impact of genetic predisposition and Rb treatments on the development of SMNs will be evaluated. Furthermore, screening and other prevention methods will be reviewed.
视网膜母细胞瘤(Rb)是一种儿童恶性眼肿瘤。后续恶性肿瘤(SMNs)和双侧性视网膜母细胞瘤(TRb)是发达国家遗传性Rb患者的主要死因。遗传性Rb患者中SMNs的高发生率归因于肿瘤抑制基因中的突变。此外,Rb的治疗选择也会影响该患者群体中SMN的发生率。将讨论最常见的SMNs和TRb的发生率及发病年龄。此外,还将评估遗传易感性和Rb治疗对SMNs发生发展的影响。此外,还将回顾筛查和其他预防方法。